HRS A-Fib Ablation Consensus Statement Offers Clinical Trial Advice
This article was originally published in The Gray Sheet
Executive Summary
A new expert 1consensus statement on ablation of atrial fibrillation, created by a Heart Rhythm Society task force, includes 21 specific recommendations for the design and conduct of clinical trials of AF ablation devices
You may also be interested in...
AF Ablation Attracts Stronger Support In Updated Clinical Guidelines
The growing use of catheter ablation to treat atrial fibrillation is supported by increasingly strong evidence, though the procedure should remain, for now, a second-line therapy to antiarrhythmic drugs, according to U.S. cardiology society guideline updates issued Dec. 20.
AF Ablation Attracts Stronger Support In Updated Clinical Guidelines
The growing use of catheter ablation to treat atrial fibrillation is supported by increasingly strong evidence, though the procedure should remain, for now, a second-line therapy to antiarrhythmic drugs, according to U.S. cardiology society guideline updates issued Dec. 20.
FDA, Cardiac Safety Research Consortium To Develop AF Ablation Registry
A consortium of academics, manufacturers and government agencies plans to launch a national atrial fibrillation ablation registry, based on input from a variety of stakeholders at a meeting April 27 and 28 at FDA's White Oak, Md., headquarters